YD23
YD23 is a PROTAC degrader of SMARCA2 with demonstrated anticancer activity. It exhibits selective growth inhibition against SMARCA4-mutant lung cancer cells in vitro, supporting its investigation in oncology research focused on synthetic lethality and targeted protein degradation.
Product Specifications
CAS Number
2951015-29-3
Product Name Alternative
EpigeneticReaderDomain, Epigenetic Reader Domain, SMARCA2, YD 23, YD-23, PROTAC
Field of Research
Epigenetics & Chromatin, Pharmacology & Drug Discovery
Purity
98.11% (May vary between batches)
Solubility
DMSO:80 mg/mL (108.29 mM) ; H2O:Insoluble.
Smiles
O=C1NC (=O) C (N2C (=O) C=3C=CC=C (NCCOCCOC4=CC=C (C=C4F) CN5CCN (C=6C=C (N=NC6N) C7=CC=CC=C7O) CC5) C3C2=O) CC1
Molecular Formula
C38H39FN8O7
Molecular Weight
738.76
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1079518-01 0.02 mg (E-Coli)
Recombinant Shewanella halifaxensis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details MBS1079518-02 0.1 mg (E-Coli)
Recombinant Shewanella halifaxensis 3-deoxy-manno-octulosonate cytidylyltransferase (kdsB)
Sign In for Pricing
View Details